Alkermes
ALKS
#3000
Rank
A$7.76 B
Marketcap
A$47.04
Share price
3.73%
Change (1 day)
-16.06%
Change (1 year)

Market capitalization of Alkermes (ALKS)

Market cap: A$7.76 Billion

As of February 2026 Alkermes has a market cap of A$7.76 Billion. This makes Alkermes the world's 3000th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alkermes from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$7.76 B10.6%
2025A$7.02 B-8.63%
2024A$7.68 B13.13%
2023A$6.79 B7.7%
2022A$6.30 B21.61%
2021A$5.18 B25.65%
2020A$4.12 B-10.18%
2019A$4.59 B-29.54%
2018A$6.52 B-39.48%
2017A$10.78 B-8%
2016A$11.71 B-28.64%
2015A$16.42 B55.55%
2014A$10.55 B68.08%
2013A$6.28 B166.16%
2012A$2.35 B7.56%
2011A$2.19 B90.37%
2010A$1.15 B16.52%
2009A$0.98 B-31.15%
2008A$1.43 B-19.72%
2007A$1.78 B4.5%
2006A$1.71 B-28.48%
2005A$2.39 B45.57%
2004A$1.64 B1.66%
2003A$1.61 B124.1%
2002A$0.72 B-78.3%
2001A$3.32 B3.52%
2000A$3.21 B68.38%
1999A$1.90 B148.74%
1998A$0.76 B20.49%
1997A$0.63 B17.48%
1996A$0.54 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Alkermes was reported to be:

A$7.76 Billion
by Nasdaq info icon info icon
A$7.76 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$836.19 B 10,665.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$455.12 B 5,759.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$217.40 B 2,698.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$160.97 B 1,972.41%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$176.74 B 2,175.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$451.27 B 5,709.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
A$2.11 B-72.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.15 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$55.65 B 616.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel